- Zacks•14 hours agoZacks.com featured highlights: Incyte, LegacyTexas Financial Group, Exelixis, Bayerische Motoren Werke Aktiengesellschaft and EQT Midstream Partners
Zacks.com featured highlights: Incyte, LegacyTexas Financial Group, Exelixis, Bayerische Motoren Werke Aktiengesellschaft and EQT Midstream Partners
- Zacks•14 hours ago
Pharmacy benefit manager Express Scripts Holding Company (ESRX) posted third-quarter 2016 earnings per share (excluding special items) of $1.74, in line with the Zacks Consensus Estimate, increasing 20% from the year-ago period.
Ligand Pharmaceuticals Incorporated (LGND) said its partner Melinta Therapeutics, a private pharma company, has submitted New Drug Applications (NDAs) to the FDA for its pipeline candidate Baxdela (delafloxacin) to treat serious bacterial infections.
Exelixis, Inc. (EXEL)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||11.06 x 100|
|Ask||13.76 x 100|
|Day's Range||11.06 - 11.63|
|52wk Range||3.55 - 15.58|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-13.31|
|Avg Vol (3m)||6,579,583|
|Dividend & Yield||N/A (N/A)|